大连新茶(大连新增保险业务)

2024-04-20 19:37:16 | 来源:上饶馆博新闻网
小字号

大连新茶(大连新增保险业务)

保险业作为一种特殊的金融服务行业,不仅在风险管理方面发挥着重要作用,也为经济的发展提供了有力支持。随着经济的快速发展,大连作为中国东北地区的重要城市,保险业也迎来了新的机遇和挑战。近年来,大连新茶——大连新增保险业务,在市场中崭露头角,为人们的生活和企业的经营带来了更多保障。

个人保险

个人保险是保险业中最常见的一种保险类别,主要包括意外险、健康险、寿险等。这些个人保险产品提供了全方位的保障,帮助个人应对突发风险和生活困境。大连新增的个人保险业务涵盖了多种类型的保险产品,使得市民在面对各种风险时能够得到及时的赔偿和帮助。

车险业务

随着大连城市的交通发展,汽车保有量急剧增加,车险业务逐渐成为大连新增保险业务的重要组成部分。车险业务不仅涉及车辆损失险,还包括第三者责任险、车上人员责任险等。大连的保险公司为车主提供了全方位的车险服务,包括在线报价、便捷理赔等。这不仅为车主提供了安心驾驶的保障,也为大连的交通安全和发展起到了积极推动的作用。

企业保险

随着大连市场经济的迅速发展,企业保险业务的需求也呈现出不断增长的趋势。大连的保险公司积极响应市场需求,推出了多样化的企业保险产品,包括财产险、责任险、信用保险等。这些企业保险产品不仅可以为企业提供财产损失的保障,还能够帮助企业应对经营风险,推动企业的健康发展。

科技保险

随着科技的快速进步,科技保险作为新兴的保险类型受到越来越多的关注。大连作为中国东北地区科技创新中心,也迎来了科技保险业务的发展。科技保险主要针对科技企业和创新项目,提供针对性的保险保障,帮助企业和项目在研发、生产和推广过程中规避风险。大连新增的科技保险业务为科技企业提供了更多的保障,推动了科技创新的发展。

总结

大连新增保险业务为大连市民和企业提供了多样化、个性化的保险服务。个人保险、车险业务、企业保险和科技保险等多个保险类别的引入充实了大连保险市场的产品线,扩大了保险业务的覆盖范围。这不仅为市民和企业提供了更多的保障选择,也为大连经济的稳定发展和风险防控提供了有力支持。


(责编:admin)

分享让更多人看到

 北流市品茶(北京流行音乐舞蹈)

北流市品茶(北京流行音乐舞蹈)

2024-04-20 19:48:17 | 来源:本领新闻网
小字号

北流市品茶

北流市品茶是一种结合了北京流行音乐和舞蹈元素的独特艺术表现形式。它融合了传统与现代的元素,展现了北京的独特魅力和文化传统。北流市品茶以其独特的节奏和动感舞蹈动作,在整个舞台上展示了流行音乐和舞蹈的完美融合。

起源与发展

北流市品茶起源于北京,是北京流行音乐舞蹈的一种变种。它最早起源于上世纪80年代,当时的北京正处于改革开放的浪潮中,流行音乐和舞蹈开始融入了生活的方方面面。北流市品茶正是在这样的背景下诞生的,它吸收了传统戏曲、北京话剧和民间舞蹈的元素,以及流行音乐的节奏和曲调。

起初,北流市品茶只是一种街舞和街头表演的形式,但随着时间的推移,它逐渐发展成一种正式的舞蹈艺术形式,并开始在剧场、演唱会等场合中演出。如今,北流市品茶已经成为一种广受欢迎的舞蹈类型,吸引了众多观众和舞蹈爱好者。

特点与表现形式

北流市品茶的舞蹈动作独特而富有张力,它结合了舞蹈和音乐的元素,通过身体的动作和音乐的节奏来感染观众。舞蹈动作充满了力量和速度感,既有快速奔放的动作,又有缓慢流畅的动作,通过动作的变化和转换来展示舞蹈的魅力。

北流市品茶的音乐曲调通常以流行和摇滚为主,这些曲调具有明快的节奏和动感的旋律,给人以活力和激情的感觉。舞者们通过跳跃、转身、旋转等动作来与音乐进行互动,表达出自己对音乐的感受和情感。

除了舞蹈动作和音乐节奏,北流市品茶还注重舞台效果和舞美设计。舞台上通常会有灯光、舞台背景和道具等元素的加入,以营造出更加丰富多彩的舞台效果。这些元素与舞蹈动作和音乐相互呼应,共同营造出一个充满魅力和张力的舞台场景。

影响与发展前景

北流市品茶对北京流行音乐和舞蹈的发展起到了积极的推动作用。它打破了传统音乐和舞蹈的束缚,融合了多元化的元素,创造出了一种新颖而受人喜爱的艺术形式。

随着时代的变迁和人们对艺术形式的追求不断提高,北流市品茶有着广阔的发展前景。它不仅可以在舞台上演出,还可以通过网络和社交媒体传播,吸引更多的观众和舞蹈爱好者。

总之,北流市品茶是北京流行音乐舞蹈中的一颗璀璨明珠。它不仅展示了北京的独特魅力和文化传统,还融合了现代的流行音乐和舞蹈元素,为观众带来了耳目一新的艺术享受。随着时间的推移和发展的不断壮大,相信北流市品茶将会在北京流行音乐舞蹈的领域中继续发光发亮。


(责编:admin)

分享让更多人看到

Asia Cell & Gene Therapy Innovation Summit 2024
  • Apr. 2nd - 3rd 2024
  • Shanghai, China

CGT Asia 2024 - The 5th Asia Cell & Gene Therapy Innovation Summit 2024
3DCC 2024 - The 2nd 3D Cell Culture and Organoid R&D Summit
CGT Awards - 2024 Asia Pacific Cell and Gene Therapy Innovation Star of the Year Award

0 +

Keynote
Speeches

0 +

Professional
Attendees

0 +

Featured
Booths

0 +

Global Cell&Gene
Therapy Enterprises

0 +

Media
Reports

Key words of the conference

Commercialization and Innovative Drug Access to Hospitals, Clinically Oriented and Innovative Therapies, Stem Cell Therapy, Extracellular Vesicles Therapy, MSC EV, Cell Therapy, Gene Therapy, RNA Therapy, Oncolytic Virus, Rare Disease, Tumor Microenvironment, Non-coding RNAs, Epigenetic, Single-Cell Sequencing, Biomarkers, Universal Cancer only Maker (UCOM), Immune Cell, TCR-T, CAR-NK, 3D Cell Culture, Organoid Model, CRISPR/CAS9 Gene Editing, iPSC, PCR, High-Throughput Screening, Application Plans,Continuous Production Process, GMP, AAV, (Non-) Viral Vectors, LNP etc.

Chips-on-Organoid, Microfluidic Technology, 3D Bio-Printing,Organoid vascularization, Advances in Cutting-Edge Technologies, Standardization and Application Scenarios, Clinical Research Applications, Drug Sensitivity Screening, R&D Applications, Efficacy Study, Cross-Cutting Technologies, Regenerative Medicine, Discussions on Laws and Regulations, etc.

Topics Highlights
The 5th Asia Cell and Gene Therapy Innovation Summit 2024
  • Case Study of Marketed Targeting CD19 CAR-T Cell Therapy Clinical Trials

  • Progress of Clinical Research on Mesenchymal Stem Cell Therapy for End-Stage Liver Disease

  • Highlights of Before and After Marketing Changes for Cell Therapy Drugs

  • Top CDMO Takes Your Cell Culture from Customization to Global Standardization

  • Role and Mechanisms of Cardiac-Derived Exosomes in Oncological Cardio Therapy

  • Bring In or Going Overseas--How to Accelerate the Commercialization of Cell Therapy?

  • Recent Clinical Advances in Gene Therapy for Hereditary Deafness

  • Novel Malignant Tumor Therapeutic Strategy - Lysovirus Enhances The Anti-Tumor

    Effect of DC Vaccines

  • Efficient Dual AAV Carrier Development Optimization and Design

  • Application and Progress of Small Nucleic Acid Drugs in The Field of Chronic Diseases

    such as Cardiovascular Diseases

  • ......

2024 3D Cell Culture Organoid R&D Summit

  • Regenerative Medicine Through The Eyes of An Investor

  • Microfluidic Chip-Assisted Vascularisation of Human Brain Organoids

  • Construction of Novel Human Endometrial Organoids

  • Research on Human Bionic Organoid and Organ-on-a-Chip Based on Neural Innervation

  • Clinical Case Sharing of Heart Transplantation for Heart Failure

  • Quality Control of Organoid Drug Sensitivity Testing Throughout the Entire Process

  • ......


At a Glance

3-2312121626223a.png


3-231120145302209.png

Exhibition & Show
Exhibition & Show
Exhibition & Show
Exhibition & Show
Exhibition & Show
Exhibition & Show
Exhibition & Show


Part of Speakers

Prof. Xinhua LIN
Prof. Xinhua LIN

President

School of Life Sciences Fudan University /  Greater Bay Area Institute of Precision Medicine

Prof. Zibing JIN
Prof. Zibing JIN

Deputy President of Beijing Tongren Hospital

Beijing Tongren Hospital Capital Medical University, Beijing Institute of Ophthalmology

Prof. Cheng QIAN
Prof. Cheng QIAN

CSO

Precision Biotech

Prof. Wei ZUO
Prof. Wei ZUO

Chairman

Regend Therapeutics

Prof. Hao SHEN
Prof. Hao SHEN

CSO

FOSUNKite

Dr. Maryland Franklin
Dr. Maryland Franklin

VP

Labcorp

Dr. Aron  JAFFE
Dr. Aron JAFFE

SVP

Chroma Medicine

Prof. Jonathan  Yuin-Han LOH
Prof. Jonathan Yuin-Han LOH

Director

A*STAR IMCB

Dr. Noriyasu ISHIKAWA
Dr. Noriyasu ISHIKAWA

CEO

Solallis Bio Inc.

Dr. David DU
Dr. David DU

Co-founder, CEO

Evergreen Therapeutics

Prof. Hongming HU
Prof. Hongming HU

CSO

ImmuXell

Prof. Guoying ZHOU
Prof. Guoying ZHOU

Chairman & CEO

ImmVira

Dr. Joan SHEN
Dr. Joan SHEN

Founder & CEO

NeuShen Tx

prof. Wenbin Qian
prof. Wenbin Qian

Founder

Rongu bio

Dr. Cecilia ZHANG
Dr. Cecilia ZHANG

CSO

Biosyngen

Mrs. Lanlin WU
Mrs. Lanlin WU

CEO

Carcell Biopharma Ltd.

Dr. Baohong ZHANG
Dr. Baohong ZHANG

CEO

Epigenic Therapeutics, Inc.

Dr. Minmin SUN
Dr. Minmin SUN

Chairman & CEO

Immunofoco

Prof. Alex H. Chang
Prof. Alex H. Chang

CEO

YaKe Biotech

Dr. Huashun LI
Dr. Huashun LI

Chairman

Ascle Therapeutics

Mr. Zhenhua Luo
Mr. Zhenhua Luo

PI

The First Affiliated Hospital of Sun Yat-sen University

Prof. Peng LIU
Prof. Peng LIU

Prof

Tsinghua university

Dr. Adam ZHAO
Dr. Adam ZHAO

Founder

Anlongbio

Dr. Binghe TAN
Dr. Binghe TAN

Co-Partner, Vice President of Production and CMC

BRL Medicine Inc.

Prof. Guoqiang HUA
Prof. Guoqiang HUA

Founder of D1 Medical

D1 MEDICAL TECHNOLOGY

Dr. Jun Li
Dr. Jun Li

CEO

Fundamentatx

Prof.  Bing Zhao
Prof. Bing Zhao

Prof

fudan university

Dr. Yuan CAI
Dr. Yuan CAI

CEO/Co-Founder

Starrygene Therapeutics

PI. Liang Li
PI. Liang Li

PI

southern medical university

Dr. Xiaofang Tang
Dr. Xiaofang Tang

Dr

GBA-IPM

Dr. Yi JIN
Dr. Yi JIN

CEO

GeCell Therapeutics

Mr. Zhihui Weng
Mr. Zhihui Weng

vp

sharecaptal

Dr. Libo ZHAO
Dr. Libo ZHAO

CTO

Echo Biotech

Dr. Andrew LIN
Dr. Andrew LIN

CEO

Lingyi Biotech Co., Ltd.

Dr. Yarong LIU
Dr. Yarong LIU

Founder/CEO

Grit Biotechnology

Dr. Wenmin ZHU
Dr. Wenmin ZHU

Marketing Director

T&L Biotechnology

Prof. Donghui ZHANG
Prof. Donghui ZHANG

Prof

Hubei university

Dr. Lang Zhang
Dr. Lang Zhang

Head of CMC-PD mRNA, in vivo Platform

CorrectSequence Therapeutics

Mr. Yun LIU
Mr. Yun LIU

Chairman/President

Huayi Capital/Huayi Research Institute

Dr. Yu ZHANG
Dr. Yu ZHANG

Founder/CEO

VCANBIO Life Science

Dr. ZhengBo SU
Dr. ZhengBo SU

Chairman

TCRCure Biopharma Ltd.

Dr. Junjie PENG
Dr. Junjie PENG

Chief Physician, Colorectal Surgery

Fudan University Shanghai Cancer Center

Dr. Ming YUAN
Dr. Ming YUAN

Chairman

Huayaokangming

Dr. Ying ZHANG
Dr. Ying ZHANG

Co-founder, CTO

Nuwacell

Dr. Xiang LI
Dr. Xiang LI

Chairman&Founder&CEO

XellSmart

Dr. Qiang CHEN
Dr. Qiang CHEN

CTO

DanausGT

Dr. Xueliang YU
Dr. Xueliang YU

VP

Starna Therapeutics

Mr. Gang LU
Mr. Gang LU

vp

shlifestemcell

Mrs. Zhong ZHAO
Mrs. Zhong ZHAO

BU Head & Chief Product Officer

DXY Insight Database

Dr. Wee Kiat TAN
Dr. Wee Kiat TAN

Co-CEO & COO

CytoMed Therapeutics

Dr. Xuedong DAI
Dr. Xuedong DAI

VP

collectively known as SAFE GLP

Mr. Victor YU
Mr. Victor YU

Country Manager of Greater China

Astrea Bioseparations Ltd

Dr. Lifan WEI
Dr. Lifan WEI

Senior Investigator

INADRD, CSPC

Dr. Zhou LI
Dr. Zhou LI

CSO

Juventas Cell Therapy LLC

Mr. Jack ZHANG
Mr. Jack ZHANG

Strategy and Business Development Lead, CGT APAC

Lonza

Dr. Zhao ZHU
Dr. Zhao ZHU

Co-founder/Chairman/CEO

Neuregen Therapeutics

Dr. Ramin BAGHIRZADE
Dr. Ramin BAGHIRZADE

Global Head Commercial – Gene Therapy CDMO Services

Charles River丨Biologics Solutions

Dr. Wenji DONG
Dr. Wenji DONG

Founder & Chairman

Genmedicn

Dr. Forrest CHEN
Dr. Forrest CHEN

CSO

Zhongying Biomedical

Dr. Gaofeng ZHA
Dr. Gaofeng ZHA

CEO

MagicRNA

Mrs. Wendy LIN
Mrs. Wendy LIN

Key Account Manager

EMBALL'ISO

 Mr.Gary Wang
Mr.Gary Wang

General Manager

kanglitai

Dr. Yang YANG
Dr. Yang YANG

CEO

Genevector Biotech

Dr. Jing FAN
Dr. Jing FAN

Founder & CEO

Hopstem

Mr. Zebin LING
Mr. Zebin LING

CEO

MingCeler

Dr. Ling PENG
Dr. Ling PENG

Medical Director

TCRcure

Prof. Hua LIU
Prof. Hua LIU

Founder, Chief Scientific Officer

Xinghua Bio

Dr. Fan MO
Dr. Fan MO

Co-founder & CEO

Neoantigen

Dr. Xinpo JIANG
Dr. Xinpo JIANG

Associate Vice President of R&D

GenScript

Mrs. Gloria Teng
Mrs. Gloria Teng

Executive Partne

GTJA Investment

Prof. Shuhang WANG
Prof. Shuhang WANG

Attending Doctor

CANCER HOSPITAL CHINESE ACADEMY OF MEDICAL SCIENCE

Mr. Alex CHENG
Mr. Alex CHENG

General Manager

Tofflon

Prof. Zhiyong ZHANG
Prof. Zhiyong ZHANG

Awardee of the First Prize of National Science and Technology Progress Award of China (Top scientific awards in China);Expert of National Talent Program of China;Chief Scientist of REGEN-αGEEK

REGEN-αGEEK

Dr. Luke LI
Dr. Luke LI

BD and Commercial VP

Neurophth Therapeutics

Mrs. Emily TAN
Mrs. Emily TAN

Chief Operating Officer

Unixell Biotechnology

Prof. Mi LIU
Prof. Mi LIU

Founder

Es-Bio

Dr. Hexige Saiyin
Dr. Hexige Saiyin

Assistant professor

Fudan University

Prof. Tianqing LI
Prof. Tianqing LI

Prof

Kunming University of Science and Technology

Dr. Zaozao CHEN
Dr. Zaozao CHEN

CTO

Avatarget

Mr. Chilin WU
Mr. Chilin WU

Partner

DeHeng

Prof. Jie LIU
Prof. Jie LIU

Principal scientist

Eacin Bio

Dr. Lei WANG
Dr. Lei WANG

Department Head of the Cell Resources Center of the National Stem Cell Resource Center

Institute of Zoology, Chinese Academy of Sciences/Beijing Institute of Stem Cell and Regenerative Medicine

Dr. Yi ZHOU
Dr. Yi ZHOU

COO

AimingMed

Prof. Hongju MAO
Prof. Hongju MAO

PI

Shanghai Institute of Microsystems and Information Technology, Chinese Academy of Sciences

Prof. Huaying CHEN
Prof. Huaying CHEN

Prof

Harbin Institute of Technology

Mrs. Katie LI
Mrs. Katie LI

Head of Clinical Operation

CorrectSequence Therapeutics

Dr. Yan XU
Dr. Yan XU

VP

Binhui Biopharm



More guests will continue to update them

Ways to Attend

Increase Your Visibility. Improve Your Reputation

Normal Ticket

  • 1 Pass

  • 2 Networking Buffet Lunch

  • Simultaneous Interpretation

  • PPTs & Documentation


Exhibition Sponsor

  • 3 Passes

  • 6㎡or 9㎡ Booth for show

  • Holistic Logo Branding On-site

  • 2 Networking Buffet Lunch

  • Simultaneous Interpretation

  • PPTs& Documentation


Presentation Sponsor

( Slots Limited)

  • 5 Passes

  • 30 min Speech Opportunity

  • 1 Color AD Page

  • Panelist Discussion

  • Holistic Logo Branding On-site

  • 2 Networking Buffet Lunch

  • Simultaneous Interpretation

  • PPTs& Documentation


Gold Sponsor

(Exclusive)

  • 5 or More Passes

  • 30 min Speech Opportunity

  • 6or 9 Booth for show

  • Chairman Opportunity

  • 1 Color AD Page

  • Panelist Discussion

  • Holistic Logo Branding On-site

  • 2 Networking Buffet Lunch

  • Simultaneous Interpretation

  • PPTs& Documentation


Secure your ticket today

Early Bird tickets available now

Secure your spot at CGT Asia our special offer, and don’t go alone, enjoy the best group discount.

Register

Sponsors & Partners

Part of Previous Sponsors

1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
21
22
23
24
25
26
27
28
29
30
31
32
33
34
35
36
37
38
39
40
41
42
43
26

Part of Media Partners

今日头条
搜狐
药智网
医谷网
CPHI制药在线
会会药咖
镁客网
广动医谷
丁香会议
研发客
肽度
大健康派
生物探索
药源网
基因线上
转化医学网
现代健康网
医药健闻
中国制药设备网
细胞知聊
新康界
医诺医学
美通社
动脉网
医疗器械创新网
新浪医药
中国仪器批发网
细胞世界
戊戌数据
大健康网
嘉裕检测
肽研社
测序宝
基因君
猎药人
化学网
爱爱医
来宝网
生物咖啡茶
生物通
医学信息
中国生物器材网
分析测试百科网
全球医学会议网

Related Meetings

Presentation, Sponsorship and Exhibition

Gina Xu

Tel:86 21 5893 3801 ext.805

Mob:13601679417

Email:gina.xu@taaslabs.com

Media and Marketing Cooperation

Koala Yan

Tel:86 215893 3801 ext. 811

Mob:13341683667

Email:koala.yan@taaslabs.com

Know More Hot and informative Medical News on Biopharma, Cell& Gene etc. Follow Us Now